Early Access to Treatment

Complements existing treatment access solutions, providing immediate treatment access while patients await financial support from funding resources.

Overview

Here's how our Early Access to Treatment Services work:

Program Application:

Patients interested in receiving an early initiation pack or an early access to treatment dose, need to be enrolled in an affordability program with this scheme and to be eligible for this support. A patient needs to request this support by completing a petition form to guarantee the reimbursement of the pack value through any funding resource.

Evaluation and Eligibility:

Our team of experts reviews each application thoroughly to assess its eligibility for the Early Access Treatment. We consider several factors to ensure that patients meet the necessary criteria as terms and conditions applied.

Collaboration and Communication:

Upon acceptance for early access treatment release, we facilitate communication among the patient, distributor or pharmacy, pharmaceutical company, and potential funding resource. This collaborative approach ensures that all parties receive timely updates on treatment reimbursement and adhere to the approved program contribution rate.

Informed Consent and Financial Planning:

Participation in the Early Access to Treatment requires patients to provide a petition form consenting and acknowledging the financial commitment, including the coverage of the treatment cost and the terms and conditions.